Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

KEYNOTE-042: Should Pembrolizumab Replace Chemo for Broader Population with Adv. NSCLC?

By Beacon Medical Interchange FEATURING Jack West

0 views

October 29, 2018

Dr. Jack West reviews the KEYNOTE-042 trial of pembrolizumab vs. chemo in PD-L1-positive NSCLC, highlighting ...
read more ↘ key findings from the presentation in the Plenary Session at ASCO 2018, clinical implications, & whether it should change practice.
↖ read less

Comments 2